Philip A. Mudd

4.1k total citations
39 papers, 1.2k citations indexed

About

Philip A. Mudd is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Philip A. Mudd has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 14 papers in Immunology and 11 papers in Epidemiology. Recurrent topics in Philip A. Mudd's work include COVID-19 Clinical Research Studies (12 papers), Influenza Virus Research Studies (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Philip A. Mudd is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Influenza Virus Research Studies (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Philip A. Mudd collaborates with scholars based in United States, Australia and Brazil. Philip A. Mudd's co-authors include Ali H. Ellebedy, Jane A. O’Halloran, Jackson S. Turner, A. Darise Farris, Aaron J. Schmitz, Meagan McMahon, Shirin Strohmeier, Florian Krammer, Kenneth E. Remy and Rachel M. Presti and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Philip A. Mudd

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip A. Mudd United States 17 491 351 347 253 174 39 1.2k
Jennifer A. Fulcher United States 19 478 1.0× 428 1.2× 347 1.0× 560 2.2× 67 0.4× 43 1.4k
Yajing Fu China 17 529 1.1× 419 1.2× 147 0.4× 210 0.8× 216 1.2× 58 1.3k
Xiaowang Qu China 15 660 1.3× 131 0.4× 309 0.9× 154 0.6× 142 0.8× 35 1.0k
Simonetta Salemi Italy 20 191 0.4× 329 0.9× 256 0.7× 233 0.9× 55 0.3× 48 1.1k
Marieke Emonts Netherlands 20 194 0.4× 382 1.1× 417 1.2× 199 0.8× 49 0.3× 53 1.2k
Arjun Rustagi United States 15 871 1.8× 625 1.8× 202 0.6× 465 1.8× 394 2.3× 21 1.7k
Palaniappan Ramanathan United States 18 388 0.8× 195 0.6× 187 0.5× 223 0.9× 39 0.2× 44 927
Nancy Q. Zhao United States 9 606 1.2× 537 1.5× 116 0.3× 426 1.7× 276 1.6× 13 1.3k
Jianqi Lian China 17 298 0.6× 320 0.9× 342 1.0× 153 0.6× 48 0.3× 58 867
Eeva Broberg Sweden 24 543 1.1× 220 0.6× 901 2.6× 234 0.9× 42 0.2× 61 1.5k

Countries citing papers authored by Philip A. Mudd

Since Specialization
Citations

This map shows the geographic impact of Philip A. Mudd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Mudd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Mudd more than expected).

Fields of papers citing papers by Philip A. Mudd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Mudd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Mudd. The network helps show where Philip A. Mudd may publish in the future.

Co-authorship network of co-authors of Philip A. Mudd

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Mudd. A scholar is included among the top collaborators of Philip A. Mudd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Mudd. Philip A. Mudd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mudd, Philip A., et al.. (2024). Emergency medicine residency pathways for MD/PhD trainees: A national cross‐sectional study of physician‐scientist training programs. AEM Education and Training. 8(2). e10960–e10960. 3 indexed citations
2.
Rijnink, Willemijn F., Daniel Stadlbauer, Eduard Puente‐Massaguer, et al.. (2023). Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. Journal of Virology. 97(11). e0164622–e0164622. 10 indexed citations
3.
Koutsakos, Marios, Jackson S. Turner, Cristina Vazquez Guillamet, et al.. (2023). Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection. Clinical & Translational Immunology. 12(8). e1460–e1460. 8 indexed citations
4.
Quinn, Michael, Luis Parra-Rodriguez, Wafaa B. Alsoussi, et al.. (2023). Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination. The Journal of Immunology. 210(7). 947–958.
5.
Munigala, Satish, et al.. (2023). Predicting severe disease in patients diagnosed with seasonal influenza in the emergency department. SHILAP Revista de lepidopterología. 4(5). e13045–e13045. 2 indexed citations
6.
Liechti, Thomas, Massimo Mangino, Margaret H. Beddall, et al.. (2022). Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples. Nature Communications. 13(1). 7255–7255. 21 indexed citations
7.
Reynolds, Daniel, Cristina Vazquez Guillamet, Nicholas Borcherding, et al.. (2021). Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. The Journal of Immunology. 207(5). 1229–1238. 26 indexed citations
8.
Arthur, Laura, Ekaterina Esaulova, Denis A. Mogilenko, et al.. (2021). Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging. Nature Aging. 1(6). 535–549. 30 indexed citations
9.
Ward, Rebecca, Nima Aghaeepour, Roby P. Bhattacharyya, et al.. (2021). Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease. Open Forum Infectious Diseases. 8(11). ofab483–ofab483. 23 indexed citations
10.
Ye, Yinyin, Adam Swensen, Yang Wang, et al.. (2021). A Pilot Study of Urine Proteomics in COVID-19–Associated Acute Kidney Injury. Kidney International Reports. 6(12). 3064–3069. 4 indexed citations
11.
Cao, Lijuan, Charles Lee, James G. Krings, et al.. (2021). Asthma in patients with suspected and diagnosed coronavirus disease 2019. Annals of Allergy Asthma & Immunology. 126(5). 535–541.e2. 14 indexed citations
12.
Turner, Jackson S., Wafaa B. Alsoussi, Zhuoming Liu, et al.. (2021). SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response. Frontiers in Immunology. 11. 618402–618402. 15 indexed citations
13.
Sindelar, Miriam, Ethan Stancliffe, Michaela Schwaiger-Haber, et al.. (2021). Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Reports Medicine. 2(8). 100369–100369. 82 indexed citations
14.
Mudd, Philip A., Edmond A. Hooker, Uwe Stolz, et al.. (2020). Emergency department evaluation of patients with angiotensin converting enzyme inhibitor associated angioedema. The American Journal of Emergency Medicine. 38(12). 2596–2601. 8 indexed citations
15.
Bimber, Benjamin N., Arpita Das, Shari M. Piaskowski, et al.. (2013). Acute Phase CD8+ T Lymphocytes against Alternate Reading Frame Epitopes Select for Rapid Viral Escape during SIV Infection. PLoS ONE. 8(5). e61383–e61383. 6 indexed citations
16.
Mudd, Philip A. & David I. Watkins. (2011). Understanding animal models of elite control: windows on effective immune responses against immunodeficiency viruses. Current Opinion in HIV and AIDS. 6(3). 197–201. 16 indexed citations
17.
18.
Mudd, Philip A., Shari M. Piaskowski, Patrícia Neves, et al.. (2010). The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques—implications for recombinant vaccine design. Immunogenetics. 62(9). 593–600. 12 indexed citations
19.
Dudek, Nadine L., Philip A. Mudd, Stuart I. Mannering, et al.. (2007). T cell epitopes of the La/SSB autoantigen in humanized transgenic mice expressing the hLa class II haplotype DRB1*0301/DQB1*0201. Arthritis & Rheumatism. 56(10). 3387–3398. 18 indexed citations
20.
Mudd, Philip A., et al.. (2006). Regulatory T Cells and Systemic Lupus Erythematosus. Scandinavian Journal of Immunology. 64(3). 211–218. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer A. Fulcher Breakdown of academic impact, for papers by Yajing Fu Breakdown of academic impact, for papers by Xiaowang Qu Breakdown of academic impact, for papers by Simonetta Salemi Breakdown of academic impact, for papers by Marieke Emonts Breakdown of academic impact, for papers by Arjun Rustagi Breakdown of academic impact, for papers by Palaniappan Ramanathan Breakdown of academic impact, for papers by Nancy Q. Zhao Breakdown of academic impact, for papers by Jianqi Lian Breakdown of academic impact, for papers by Eeva Broberg
Rankless by CCL
2026